Application of a System Model for Continuous Manufacturing of an Active Pharmaceutical Ingredient in an Industrial Environment

被引:0
|
作者
Samir Diab
Gabriele Bano
Charalampos Christodoulou
Neil Hodnett
Antonio Benedetti
Markus Andersson
Simeone Zomer
机构
[1] GlaxoSmithKline (GSK),
[2] GlaxoSmithKline (GSK),undefined
[3] Present: Nexeon Ltd.,undefined
来源
关键词
Pharmaceutical manufacturing; System modelling; Process optimization; Quality by Design (QbD); Industry 4.0;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1333 / 1346
页数:13
相关论文
共 50 条
  • [1] Application of a System Model for Continuous Manufacturing of an Active Pharmaceutical Ingredient in an Industrial Environment
    Diab, Samir
    Bano, Gabriele
    Christodoulou, Charalampos
    Hodnett, Neil
    Benedetti, Antonio
    Andersson, Markus
    Zomer, Simeone
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2022, 17 (04) : 1333 - 1346
  • [2] Thin-Film Evaporator Model for Continuous Active Pharmaceutical Ingredient Manufacturing
    Lee, Boung Wook
    Yin, Kehua
    Splaine, Kevin
    Roesch, Brian
    INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2020, 59 (07) : 3252 - 3260
  • [3] Raw material variability of an active pharmaceutical ingredient and its relevance for processability in secondary continuous pharmaceutical manufacturing
    Stauffer, F.
    Vanhoorne, V.
    Pilcer, G.
    Chavez, P-F.
    Rome, S.
    Schubert, M. A.
    Aerts, L.
    De Beer, T.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 127 : 92 - 103
  • [4] Process Design and Optimization for the Continuous Manufacturing of Nevirapine, an Active Pharmaceutical Ingredient for HIV Treatment
    Diab, Samir
    McQuade, D. Tyler
    Gupton, B. Frank
    Gerogiorgis, Dimitrios I.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2019, 23 (03) : 320 - 333
  • [5] Rethinking cleaning validation for active pharmaceutical ingredient manufacturing
    Hadziselimovic, Dijana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [6] Material management in the active pharmaceutical ingredient manufacturing plant
    Wenzel, E
    PHARMAZEUTISCHE INDUSTRIE, 2003, 65 (07): : 712 - 714
  • [7] Mathematical Modeling and Optimization to Inform Impurity Control in an Industrial Active Pharmaceutical Ingredient Manufacturing Process
    Diab, Samir
    Christodoulou, Charalampos
    Taylor, George
    Rushworth, Philip
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (10) : 2864 - 2881
  • [8] Excipient-Induced Lattice Disorder in Active Pharmaceutical Ingredient: Implications on Drug Product Continuous Manufacturing
    Munjal, Bhushan
    Deboyace, Kevin
    Cao, Fengjuan
    Krzyzaniak, Joseph F.
    Arora, Kapildev K.
    Suryanarayanan, Raj
    MOLECULAR PHARMACEUTICS, 2024, 21 (10) : 5150 - 5158
  • [9] Application of Mid-Infrared Spectroscopy to the Development and Transfer of a Manufacturing Process for an Active Pharmaceutical Ingredient
    Clegg, Ian M.
    Daly, Adrian M.
    Donnelly, Craig
    Hardy, Ruth
    Harris, Denise
    Jackman, Hayley
    Jones, Ricky
    Luan, Amy
    McAndrew, Douglas
    McGauley, Pat
    Pearce, John
    Scotney, Gemma
    Yeow, May-Ling
    APPLIED SPECTROSCOPY, 2012, 66 (05) : 574 - 579
  • [10] Industrial-Scale Continuous Vacuum Drying of Active Pharmaceutical Ingredient Paste: Determination of the Process Window
    Aigner, Isabella
    Zettl, Manuel
    Schroettner, Hartmuth
    van der Wel, Peter
    Khinast, Johannes G.
    Krumme, Markus
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2022, 26 (02) : 323 - 334